Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/8/26 16:20 | 9/4/26 | MAZE | Health | BioPrd | Biological Products, (No Diag | Bernstein Harold | CA | O | P,R,D,CM | 13 | S.dm | -8,596 | 37.28 | 0 | -231 | 10 | D | |||||||||||||||
9/4/26 16:27 | 9/2/26 | MAZE | Health | BioPrd | Biological Products, (No Diag | Courtney Phillips | CA | O | GC,Corp. | 1 | S.m | -105 | 26.24 | 0 | -4 | 7 | D | |||||||||||||||
9/4/26 16:25 | 9/2/26 | MAZE | Health | BioPrd | Biological Products, (No Diag | Dandekar Atul | CA | O | CSBO | 9 | S.dm | -4,671 | 35.54 | 0 | -131 | 32 | D | |||||||||||||||
9/4/26 16:24 | 9/2/26 | MAZE | Health | BioPrd | Biological Products, (No Diag | Coloma Jason V | CA | DO | CEO | 7 | S.m | -4,348 | 27.06 | 0 | -161 | 412 | D | |||||||||||||||
4/2/26 16:06 | 4/1/26 | MAZE | Health | BioPrd | Biological Products, (No Diag | Bachrodt Amy | CA | O | SVP,Fina | 5 | S.dm | -1,333 | 41.03 | 0 | -33 | 13 | D | |||||||||||||||
1/8/26 16:30 | 1/6/26 | MAZE | Health | BioPrd | Biological Products, (No Diag | Sohn Catherine A. | CA | D | 1 | S.dm | -1,149 | 39.07 | 0 | -29 | -100 | 0 | D | |||||||||||||||
9/16/25 16:26 | 9/15/25 | MAZE | Health | BioPrd | Biological Products, (No Diag | Scheller Richard H | CA | D | 1 | S | -464 | 22.37 | 0 | -21 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |